You have 9 free searches left this month | for more free features.

Lymphoma, Non-Hodgkin

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Lymphoma, Non-Hodgkin Lymphoma, B-Cell Trial (BAFF CAR-T)

Not yet recruiting
  • Lymphoma, Non-Hodgkin Lymphoma, B-Cell
  • BAFF CAR-T
  • (no location specified)
Aug 16, 2022

Lymphoma, Non-Hodgkin, Diffuse Large B Cell Lymphoma, Follicular Lymphoma Trial in New York (Venetoclax, Tazemetostat)

Not yet recruiting
  • Lymphoma, Non-Hodgkin
  • +2 more
  • New York, New York
    Weill Cornell Medicine/NewYork-Presberteryian Hospital
Nov 15, 2022

Living Conditions After Non-Hodgkin's Lymphoma in France

Not yet recruiting
  • Non-hodgkin's Lymphoma
  • Data collection
  • Questionnaires
  • Dijon, France
    Chu Dijon Bourgogne
Oct 13, 2022

Relapsed Non-Hodgkin Lymphoma, Refractory Non-Hodgkin Lymphoma, Non Hodgkin Lymphoma Trial in Jinan (CAR-T cells)

Recruiting
  • Relapsed Non-Hodgkin Lymphoma
  • +2 more
  • CAR-T cells
  • Jinan, Shandong, China
    The Second People's Hospital of Shandong Province
Jun 14, 2022

Immunogenicity of COVID-19 Vaccinations in Autologous HSCT

Not yet recruiting
  • COVID-19
  • +2 more
    • Cologne, NRW, Germany
      University Hospital of Cologne
    Oct 27, 2022

    Lymphoma, Non-Hodgkin, Relapsed Non Hodgkin Lymphoma, Refractory B-Cell Non-Hodgkin Lymphoma Trial in United States (CB-010,

    Recruiting
    • Lymphoma, Non-Hodgkin
    • +6 more
    • CB-010
    • +2 more
    • Scottsdale, Arizona
    • +7 more
    Aug 19, 2022

    Lymphoma, Non-Hodgkin Trial in Saint Louis (Stem cell infusion, TLI, Anti-thymocyte globulin)

    Active, not recruiting
    • Lymphoma, Non-Hodgkin
    • Stem cell infusion
    • +5 more
    • Saint Louis, Missouri
      Washington University
    Jan 12, 2022

    Relapsed Non Hodgkin Lymphoma, Refractory Non-Hodgkin Lymphoma Trial in Cleveland (Loncastuximab tesirine, Venetoclax)

    Recruiting
    • Relapsed Non Hodgkin Lymphoma
    • Refractory Non-Hodgkin Lymphoma
    • Cleveland, Ohio
      Cleveland Clinic Taussig Cancer Center, Case Comprehensive Cance
    May 20, 2022

    Non-hodgkin Lymphoma, Hodgkin Lymphoma, Lymphoma Trial in Chicago (Radiation - Dose Level 0, Radiation - Dose Level 1, Radiation

    Recruiting
    • Non-hodgkin Lymphoma
    • +2 more
    • Radiation - Dose Level 0
    • +4 more
    • Chicago, Illinois
      University of Chicago
    Dec 3, 2021

    Non Hodgkin Lymphoma Trial in Cologne, Essen (CTL019)

    Active, not recruiting
    • Non Hodgkin Lymphoma
    • Cologne, Germany
    • +1 more
    Mar 2, 2022

    Hodgkin's Lymphoma, Lymphoma, Non-Hodgkin Trial in Ann Arbor (Bortezomib, Ruxolitinib)

    Completed
    • Hodgkin's Lymphoma
    • Lymphoma, Non-Hodgkin
    • Ann Arbor, Michigan
      University of Michgan Comprehensive Cancer Center
    Dec 3, 2021

    DLBCL - Diffuse Large B Cell Lymphoma, High-grade B-cell Lymphoma, Follicular Lymphoma Trial (Bridging radiation therapy,

    Not yet recruiting
    • DLBCL - Diffuse Large B Cell Lymphoma
    • +6 more
    • Bridging radiation therapy
    • +2 more
    • (no location specified)
    Nov 11, 2022

    Non-Hodgkin's Lymphoma Trial in Vitoria-Gasteiz (RiTUXimab Injection [Truxima])

    Recruiting
    • Non-Hodgkin's Lymphoma
    • RiTUXimab Injection [Truxima]
    • Vitoria-Gasteiz, Alava, Spain
      Hospital Universitario Araba- Sede Txagorritxu
    Mar 30, 2022

    Lymphoma, Lymphoma, B-Cell, Lymphoma, T-Cell Trial in New York (Pharmacokinetics)

    Recruiting
    • Lymphoma
    • +4 more
    • Pharmacokinetics
    • New York, New York
      Memorial Sloan Kettering Cancer Center
    Sep 12, 2022

    B-cell Non-Hodgkin Lymphoma, Diffuse Large B Cell Lymphoma, Follicular Lymphoma Trial (IKS03)

    Not yet recruiting
    • B-cell Non-Hodgkin Lymphoma
    • +4 more
    • (no location specified)
    May 6, 2022

    Solid Tumor, Non-Hodgkin Lymphoma Trial in Shanghai, Hangzhou (Gentulizumab)

    Recruiting
    • Solid Tumor
    • Non-Hodgkin Lymphoma
    • Shanghai, Shanghai, China
    • +1 more
    Jan 21, 2022

    Non-hodgkin's Lymphoma Trial in Langfang (CD19+22 CAR-T cells)

    Recruiting
    • Non-hodgkin's Lymphoma
    • CD19+22 CAR-T cells
    • Langfang, Hebei, China
      Hebei Yanda Ludaopei Hospital
    Jan 11, 2022

    Non-Hodgkin Lymphoma, Hodgkin Lymphoma Trial in Minneapolis (drug, procedure, biological, radiation)

    Recruiting
    • Non-Hodgkin Lymphoma
    • Hodgkin Lymphoma
    • Minneapolis, Minnesota
      Masonic Cancer Center, University of Minnesota
    Jan 3, 2022

    Young Adults, Lymphoma, Non-Hodgkin, Hodgkin Disease Trial in Clermont-Ferrand (Indirect calorimetric test during submaximal

    Recruiting
    • Young Adults
    • +2 more
    • Indirect calorimetric test during submaximal exercise
    • Clermont-Ferrand, France
      CHU de Clermont-Ferrand
    May 3, 2022

    CD20-positive Non-Hodgkin Lymphoma Trial in Seoul (Rituximab + MG4101)

    Active, not recruiting
    • CD20-positive Non-Hodgkin Lymphoma
    • Rituximab + MG4101
    • Seoul, Korea, Republic of
      Seoul National University Hospital
    Feb 4, 2022

    Lymphoma, Non-Hodgkin, Lymphoma, Hodgkin Trial (intervention)

    Not yet recruiting
    • Lymphoma, Non-Hodgkin
    • Lymphoma, Hodgkin
    • intervention
    • (no location specified)
    Feb 9, 2022

    Non-Hodgkin's Lymphoma and Hodgkin's Disease

    Recruiting
    • Lymphoma, Non-Hodgkin
    • Hodgkin's Disease
      • Stanford, California
        Stanford University School of Medicine
      Aug 2, 2021

      Mature B-Cell Non-Hodgkin Lymphoma Trial (Obinutuzumab, Glofitamab, Rituximab)

      Not yet recruiting
      • Mature B-Cell Non-Hodgkin Lymphoma
      • (no location specified)
      Sep 6, 2022

      Solid Tumor, Non Hodgkin Lymphoma Trial in Guangzhou (ADG106 injection, PD-1 antibody injection)

      Recruiting
      • Solid Tumor
      • Non Hodgkin Lymphoma
      • ADG106 injection
      • PD-1 antibody injection
      • Guangzhou, Guangdong, China
        Sun Yat-Sen University Cancer Center
      Jan 11, 2022

      B-cell Malignancy, Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial (AS-1763)

      Not yet recruiting
      • B-cell Malignancy
      • +7 more
      • (no location specified)
      Oct 26, 2022